Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study.

Autor: Suzuki, Daniele Assad¹ (AUTHOR), Morelle, Alessandra Menezes² (AUTHOR), de Brito, Mayana Lopes³ (AUTHOR), Paes, Flavia Rocha⁴ (AUTHOR), Mattar, André⁵ (AUTHOR), Leal, Jorge H. Santos⁶ (AUTHOR), Simon, Sérgio D.⁷ (AUTHOR), Lima, Ellias Magalhães Abreu⁸ (AUTHOR), Werutsky, Gustavo⁹ (AUTHOR), Piotto, Gustavo H. Munhoz¹⁰ (AUTHOR), Bines, José¹¹ (AUTHOR), Damiani, Lucas Petri¹² (AUTHOR), Macedo, Ariane¹³ (AUTHOR), Campos, Lígia¹⁴ (AUTHOR), Buehler, Anna Maria¹⁴ (AUTHOR) anna.buehler@novartis.com

Publikováno v: JCO Global Oncology. 4/11/2024, Vol. 10, p1-13. 13p.